Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02937987
  4. Details
NCT02937987 Clinical Trial

Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients

Type 2 Diabetes Mellitus in Obese Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02937987
Other study ID # Lifestyle-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2016
Est. completion date March 2018

Study information
Verified date January 2019
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to describe and examine the dietary intake, eating behavior and physical activity level of a cohort of Hong Kong Chinese with T2DM and their association with weight and glycemic control at baseline and 1 year follow-up. The investigators hypothesize that Hong Kong Chinese T2DM patients with unhealthy dietary intake and pattern and low physical activity level are associated with poorer glycemic and weight control, and there will be no improvement with weight and glycemic control under usual care after 1 year.

Recruitment information / eligibility
Status Completed
Enrollment 211
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Male or female of Chinese ethnicity

2. Diagnosis of T2DM

3. Able to read Chinese and give informed written consents

Exclusion Criteria:

1. Type 1 diabetes mellitus

2. End-stage renal failure requiring dialysis or chronic kidney disease (CKD) stage 4 or above

3. Malignancy diagnosed within 3 years

4. Pregnancy or lactation

5. Any medical illness or condition as judged by the investigators as ineligible to participate the study

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Chinese University of Hong Kong

Outcome
Type Measure Description Time frame Safety issue
Primary Change of HbA1c 1 year
Primary Change of Weight 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05606471 - Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets Phase 4
Completed NCT05072990 - Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Withdrawn NCT02977039 - Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity N/A
Recruiting NCT06223490 - Effect of Cryolipolysis on Insulin Resistance N/A
Completed NCT04363710 - Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet N/A
Recruiting NCT05277558 - Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Recruiting NCT04621929 - Obesity and Uric Acid Stones Study Phase 3
Completed NCT04332354 - Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
Completed NCT05890950 - A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes Phase 1
Not yet recruiting NCT06442150 - LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences N/A
Withdrawn NCT04910997 - Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes N/A
Completed NCT04931836 - The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults N/A
Recruiting NCT06005012 - Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM Phase 2
Completed NCT05409027 - A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62 Phase 1
Terminated NCT04741074 - Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy Phase 3
Recruiting NCT05838287 - Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants Phase 4
Active, not recruiting NCT04916314 - REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes N/A
Completed NCT04303819 - The Effect of Exenatide on Fasting Bile Acids
Recruiting NCT05446415 - L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP N/A
Completed NCT05770076 - Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) N/A